{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:32:19Z","timestamp":1793133139157,"version":"4.5.0"},"posted":{"date-parts":[[2026,6,11]]},"group-title":"In Review","reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,3]]},"abstract":"<title>Abstract<\/title>\n                <p>Objective\n The evidence supporting the benefit of statins in the treatment of primary open-angle glaucoma (POAG) is mixed, and their effect among patients of African ancestry is largely unexplored. This study examines the association of statins with the prevalence and severity of POAG in this ancestry group.\nDesign:\n Cross-sectional study.\nSubjects:\n 5715 subjects of African ancestry (African American, African descent, or African Caribbean) ages 35 and older, recruited from ophthalmology clinics in the University of Pennsylvania Health System as part of the Primary Open-Angle African Ancestry Glaucoma Genetics (POAAGG) study.\nMethods\n Logistic regression was used to analyze the prevalence of POAG in statin users versus non-users, adjusting for demographic and clinical co-variates. Sub-analyses compared POAG prevalence between high-potency and low-potency statin users. Ocular endophenotypes were compared between statin users and non-users.\nMain Outcome Measures:\n POAG prevalence, ocular endophenotypes.\nResults\n POAG prevalence did not differ between statin users and non-users (OR: 0.99, 95% CI: 0.85, 1.14; p\u2009=\u20090.84). Among POAG cases, statin users had significantly smaller mean cup-to-disc ratio (mean difference [MD]=-0.03, 95% CI: -0.04, -0.01, p\u2009&lt;\u20090.001), better visual acuity (MD=-0.10, 95% CI: -0.16, -0.04, p\u2009=\u20090.001), thicker mean retinal nerve fiber layers (MD\u2009=\u20091.43, 95% CI: 0.18, 2.68, p\u2009=\u20090.03), and lower mean pattern standard deviation values (MD=-0.39, 95% CI: -0.66, -0.13, p\u2009=\u20090.004) than non-users.\nConclusion\n Statin use was not associated with POAG prevalence but was associated with milder structural and functional disease features among cases. These findings suggest the need for further investigation of the effect of statins in African ancestry patients with POAG.<\/p>","DOI":"10.21203\/rs.3.rs-9911540\/v1","type":"posted-content","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:30:36Z","timestamp":1781173836000},"source":"Crossref","is-referenced-by-count":0,"title":["Statin Use and Primary Open-Angle Glaucoma Severity in Patients of African Ancestry"],"prefix":"10.21203","author":[{"given":"Marine-Ayan Ibrahim","family":"Aibo","sequence":"first","affiliation":[{"name":"Penn Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Di","family":"Rosa","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmi","family":"Moksha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-8962","authenticated-orcid":false,"given":"Aaron","family":"Zhao","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Perelman School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Salowe","sequence":"additional","affiliation":[{"name":"University of Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Addis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-shuang","family":"Ying","sequence":"additional","affiliation":[{"name":"University of Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Penn Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"2","key":"ref1","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"Steinmetz JD","year":"2021","unstructured":"Steinmetz JD, Bourne RRA, Briant PS, Flaxman SR, Taylor HRB, Jonas JB, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e144\u201360. doi:10.1016\/S2214-109X(20)30489-7","journal-title":"Lancet Glob Health"},{"issue":"1","key":"ref2","doi-asserted-by":"publisher","first-page":"13762","DOI":"10.1038\/s41598-021-92971-w","article-title":"Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review","volume":"11","author":"Zhang N","year":"2021","unstructured":"Zhang N, Wang J, Li Y, Jiang B. Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci Rep. 2021;11(1):13762. doi:10.1038\/s41598-021-92971-w","journal-title":"Sci Rep"},{"issue":"3","key":"ref3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/jama.1991.03470030069026","article-title":"Racial Variations in the Prevalence of Primary Open-angle Glaucoma: The Baltimore Eye Survey","volume":"266","author":"Tielsch JM","year":"1991","unstructured":"Tielsch JM. Racial Variations in the Prevalence of Primary Open-angle Glaucoma: The Baltimore Eye Survey. JAMA. 1991;266(3):369. doi:10.1001\/jama.1991.03470030069026","journal-title":"JAMA"},{"issue":"2","key":"ref4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.cell.2023.12.006","article-title":"A multi-cohort genome-wide association study in African ancestry individuals reveals risk loci for primary open-angle glaucoma","volume":"187","author":"Verma SS","year":"2024","unstructured":"Verma SS, Gudiseva HV, Chavali VRM, Salowe RJ, Bradford Y, Guare L, et al. A multi-cohort genome-wide association study in African ancestry individuals reveals risk loci for primary open-angle glaucoma. Cell. 2024;187(2):464\u2013480.e10. doi:10.1016\/j.cell.2023.12.006","journal-title":"Cell"},{"issue":"1","key":"ref5","doi-asserted-by":"publisher","first-page":"16067","DOI":"10.1038\/nrdp.2016.67","article-title":"Primary open-angle glaucoma","volume":"2","author":"Weinreb RN","year":"2016","unstructured":"Weinreb RN, Leung CKS, Crowston JG, Medeiros FA, Friedman DS, Wiggs JL, et al. Primary open-angle glaucoma. Nat Rev Dis Primer. 2016;2(1):16067. doi:10.1038\/nrdp.2016.67","journal-title":"Nat Rev Dis Primer"},{"issue":"2","key":"ref6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/eye.2015.244","article-title":"A view on glaucoma\u2014are we seeing it clearly?","volume":"30","author":"Crabb DP","year":"2016","unstructured":"Crabb DP. A view on glaucoma\u2014are we seeing it clearly? Eye. 2016;30(2):304\u201313. doi:10.1038\/eye.2015.244","journal-title":"Eye"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/ICU.0b013e32832401a9","article-title":"Glaucoma and disability: which tasks are affected, and at what stage of disease?","volume":"20","author":"Ramulu P","year":"2009","unstructured":"Ramulu P. Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol. 2009;20(2):92\u20138. doi:10.1097\/ICU.0b013e32832401a9","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"ref8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2020.21899","article-title":"Glaucoma in Adults\u2014Screening, Diagnosis, and Management: A Review","volume":"325","author":"Stein JD","year":"2021","unstructured":"Stein JD, Khawaja AP, Weizer JS. Glaucoma in Adults\u2014Screening, Diagnosis, and Management: A Review. JAMA. 2021;325(2):164. doi:10.1001\/jama.2020.21899","journal-title":"JAMA"},{"issue":"6","key":"ref9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/01.APO.0000605096.48529.9c","article-title":"Latest Developments in Normal-Pressure Glaucoma: Diagnosis, Epidemiology, Genetics, Etiology, Causes and Mechanisms to Management","volume":"8","author":"Lee JWY","year":"2019","unstructured":"Lee JWY, Chan PP, Zhang X, Chen LJ, Jonas JB. Latest Developments in Normal-Pressure Glaucoma: Diagnosis, Epidemiology, Genetics, Etiology, Causes and Mechanisms to Management. Asia-Pac J Ophthalmol. 2019;8(6):457\u201368. doi:10.1097\/01.APO.0000605096.48529.9c","journal-title":"Asia-Pac J Ophthalmol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1001\/archopht.120.4.471","article-title":"A Population-Based Cross-sectional Survey in a Rural District in South Africa","volume":"120","author":"Rotchford AP","year":"2002","unstructured":"Rotchford AP, Johnson GJ. A Population-Based Cross-sectional Survey in a Rural District in South Africa. ARCH OPHTHALMOL. 2002;120.","journal-title":"ARCH OPHTHALMOL"},{"key":"ref11","volume-title":"Clinical Profiles of Primary Open Angle Glaucoma versus Normal Tension Glaucoma Patients","author":"Asrani S","unstructured":"Asrani S, Samuels B, Thakur M, Santiago C. Clinical Profiles of Primary Open Angle Glaucoma versus Normal Tension Glaucoma Patients: A Pilot St. Curr Eye Res."},{"issue":"2","key":"ref12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.atherosclerosis.2008.12.023","article-title":"Statins inhibit Rho kinase activity in patients with atherosclerosis","volume":"205","author":"Nohria A","year":"2009","unstructured":"Nohria A, Prsic A, Liu PY, Okamoto R, Creager MA, Selwyn A, et al. Statins inhibit Rho kinase activity in patients with atherosclerosis. Atherosclerosis. 2009;205(2):517\u201321. doi:10.1016\/j.atherosclerosis.2008.12.023","journal-title":"Atherosclerosis"},{"issue":"22","key":"ref13","doi-asserted-by":"publisher","first-page":"12500","DOI":"10.3390\/ijms222212500","article-title":"Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension","volume":"22","author":"Kim ML","year":"2021","unstructured":"Kim ML, Sung KR, Kwon J, Choi GW, Shin JA. Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension. Int J Mol Sci. 2021;22(22):12500. doi:10.3390\/ijms222212500","journal-title":"Int J Mol Sci"},{"issue":"5","key":"ref14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/jamacardio.2023.0228","article-title":"Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020","volume":"8","author":"Jacobs JA","year":"2023","unstructured":"Jacobs JA, Addo DK, Zheutlin AR, Derington CG, Essien UR, Navar AM, et al. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020. JAMA Cardiol. 2023;8(5):443. doi:10.1001\/jamacardio.2023.0228","journal-title":"JAMA Cardiol"},{"issue":"4","key":"ref15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3390\/healthcare8040361","article-title":"Factors Associated with Disparities in Appropriate Statin Therapy in an Outpatient Inner City Population","volume":"8","author":"Suero-Abreu GA","year":"2020","unstructured":"Suero-Abreu GA, Karatasakis A, Rashid S, Tysarowski M, Douglas A, Patel R, et al. Factors Associated with Disparities in Appropriate Statin Therapy in an Outpatient Inner City Population. Healthcare. 2020;8(4):361. doi:10.3390\/healthcare8040361","journal-title":"Healthcare"},{"issue":"1","key":"ref16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41433-019-0603-z","article-title":"A review of systemic medications that may modulate the risk of glaucoma","volume":"34","author":"Wu A","year":"2020","unstructured":"Wu A, Khawaja AP, Pasquale LR, Stein JD. A review of systemic medications that may modulate the risk of glaucoma. Eye. 2020;34(1):12\u201328. doi:10.1038\/s41433-019-0603-z","journal-title":"Eye"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajo.2025.04.003","article-title":"Racial and Ethnic Differences in the Association Between Statin Use and the Risk of Ocular Hypertension and Open-Angle Glaucoma","volume":"276","author":"Elhusseiny AM","year":"2025","unstructured":"Elhusseiny AM, Eleiwa TK, Dihan QA, Chauhan MZ, Al\u2019Aref SJ, Lee RK. Racial and Ethnic Differences in the Association Between Statin Use and the Risk of Ocular Hypertension and Open-Angle Glaucoma. Am J Ophthalmol. 2025;276:117\u201325. doi:10.1016\/j.ajo.2025.04.003","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"ref18","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1016\/j.ophtha.2012.04.029","article-title":"The Relationship Between Statin Use and Open-Angle Glaucoma","volume":"119","author":"Stein JD","year":"2012","unstructured":"Stein JD, Newman-Casey PA, Talwar N, Nan B, Richards JE, Musch DC. The Relationship Between Statin Use and Open-Angle Glaucoma. Ophthalmology. 2012;119(10):2074\u201381. doi:10.1016\/j.ophtha.2012.04.029","journal-title":"Ophthalmology"},{"issue":"6","key":"ref19","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/archopht.122.6.822","article-title":"Statins and Other Cholesterol-Lowering Medications and the Presenceof Glaucoma","volume":"122","author":"McGwin G","year":"2004","unstructured":"McGwin G. Statins and Other Cholesterol-Lowering Medications and the Presenceof Glaucoma. Arch Ophthalmol. 2004;122(6):822. doi:10.1001\/archopht.122.6.822","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"ref20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1001\/jamaophthalmol.2016.5406","article-title":"Association of Daily Dosage and Type of Statin Agent With Risk of Open-Angle Glaucoma","volume":"135","author":"Talwar N","year":"2017","unstructured":"Talwar N, Musch DC, Stein JD. Association of Daily Dosage and Type of Statin Agent With Risk of Open-Angle Glaucoma. JAMA Ophthalmol. 2017;135(3):263. doi:10.1001\/jamaophthalmol.2016.5406","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"ref21","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1167\/iovs.15-18595","article-title":"The Effect of Statins on Intraocular Pressure and on the Incidence and Progression of Glaucoma: A Systematic Review and Meta-Analysis","volume":"57","author":"McCann P","year":"2016","unstructured":"McCann P, Hogg RE, Fallis R, Azuara-Blanco A. The Effect of Statins on Intraocular Pressure and on the Incidence and Progression of Glaucoma: A Systematic Review and Meta-Analysis. Investig Opthalmology Vis Sci. 2016;57(6):2729. doi:10.1167\/iovs.15-18595","journal-title":"Investig Opthalmology Vis Sci"},{"issue":"45","key":"ref22","doi-asserted-by":"publisher","first-page":"e2018","DOI":"10.1097\/MD.0000000000002018","article-title":"Association Between Statin Use and Open-angle Glaucoma in Hyperlipidemia Patients: A Taiwanese Population-based Case-control Study","volume":"94","author":"Chen HY","year":"2015","unstructured":"Chen HY, Hsu SY, Chang YC, Lin CC, Sung FC, Chen WC, et al. Association Between Statin Use and Open-angle Glaucoma in Hyperlipidemia Patients: A Taiwanese Population-based Case-control Study. Medicine (Baltimore). 2015;94(45):e2018. doi:10.1097\/MD.0000000000002018","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"ref23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ophtha.2014.11.015","article-title":"The Primary Open-Angle African American Glaucoma Genetics Study","volume":"122","author":"Charlson ES","year":"2015","unstructured":"Charlson ES, Sankar PS, Miller-Ellis E, Regina M, Fertig R, Salinas J, et al. The Primary Open-Angle African American Glaucoma Genetics Study. Ophthalmology. 2015;122(4):711\u201320. doi:10.1016\/j.ophtha.2014.11.015","journal-title":"Ophthalmology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000416","author":"Salowe RJ","year":"2022","unstructured":"Salowe RJ, Lee R, Zenebe-Gete S, Vaughn M, Gudiseva HV, Pistilli M, et al. Recruitment strategies and lessons learned from a large genetic study of African Americans. Dimaras H, editor. PLOS Glob Public Health. 2022;2(8):e0000416. doi:10.1371\/journal.pgph.0000416"},{"issue":"5","key":"ref25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1167\/iovs.63.5.31","article-title":"Statin Use in Relation to Intraocular Pressure, Glaucoma, and Ocular Coherence Tomography Parameters in the UK Biobank","volume":"63","author":"Kim J","year":"2022","unstructured":"Kim J, Kennedy Neary MT, Aschard H, Palakkamanil MM, Do R, Wiggs JL, et al. Statin Use in Relation to Intraocular Pressure, Glaucoma, and Ocular Coherence Tomography Parameters in the UK Biobank. Investig Opthalmology Vis Sci. 2022;63(5):31. doi:10.1167\/iovs.63.5.31","journal-title":"Investig Opthalmology Vis Sci"},{"issue":"2","key":"ref26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. doi:10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi:10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"101364","DOI":"10.1016\/j.eclinm.2022.101364","article-title":"Associations of statin use with the onset and progression of open-angle glaucoma: A systematic review and meta-analysis","volume":"46","author":"Yuan Y","year":"2022","unstructured":"Yuan Y, Xiong R, Wu Y, Ha J, Wang W, Han X, et al. Associations of statin use with the onset and progression of open-angle glaucoma: A systematic review and meta-analysis. eClinicalMedicine. 2022;46:101364. doi:10.1016\/j.eclinm.2022.101364","journal-title":"eClinicalMedicine"},{"issue":"1","key":"ref29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/bjophthalmol-2021-318789","article-title":"Association between statin use and the risks of glaucoma in Australia: a 10-year cohort study","volume":"107","author":"Yuan Y","year":"2023","unstructured":"Yuan Y, Wang W, Shang X, Xiong R, Ha J, Zhang L, et al. Association between statin use and the risks of glaucoma in Australia: a 10-year cohort study. Br J Ophthalmol. 2023;107(1):66\u201371. doi:10.1136\/bjophthalmol-2021-318789","journal-title":"Br J Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2024.07.008","article-title":"Associations between Statin Use and Glaucoma in the All of Us Research Program","volume":"S2589419624001376","author":"Lee SY","year":"2024","unstructured":"Lee SY, Paul ME, Coleman AL, Kitayama K, Yu F, Pan D, et al. Associations between Statin Use and Glaucoma in the All of Us Research Program. Ophthalmol Glaucoma. 2024;S2589419624001376. doi:10.1016\/j.ogla.2024.07.008","journal-title":"Ophthalmol Glaucoma"},{"issue":"6","key":"ref31","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1471-4159.2004.02980.x","article-title":"Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones","volume":"92","author":"B\u00f6sel J","year":"2005","unstructured":"B\u00f6sel J, Gandor F, Harms C, Synowitz M, Harms U, Djoufack PC, et al. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J Neurochem. 2005;92(6):1386\u201398. doi:10.1111\/j.1471-4159.2004.02980.x","journal-title":"J Neurochem"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"101225","DOI":"10.1016\/j.mam.2023.101225","article-title":"Novel frontiers in neuroprotective therapies in glaucoma: Molecular and clinical aspects","volume":"94","author":"Boccaccini A","year":"2023","unstructured":"Boccaccini A, Cavaterra D, Carnevale C, Tanga L, Marini S, Bocedi A, et al. Novel frontiers in neuroprotective therapies in glaucoma: Molecular and clinical aspects. Mol Aspects Med. 2023;94:101225. doi:10.1016\/j.mam.2023.101225","journal-title":"Mol Aspects Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.exer.2016.08.023","article-title":"Role of the Rho GTPase\/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research","volume":"158","author":"Rao PV","year":"2017","unstructured":"Rao PV, Pattabiraman PP, Kopczynski C. Role of the Rho GTPase\/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research. Exp Eye Res. 2017;158:23\u201332. doi:10.1016\/j.exer.2016.08.023","journal-title":"Exp Eye Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.05.002","article-title":"Rho-associated kinase inhibitors: A novel glaucoma therapy","volume":"37","author":"Inoue T","year":"2013","unstructured":"Inoue T, Tanihara H. Rho-associated kinase inhibitors: A novel glaucoma therapy. Prog Retin Eye Res. 2013;37:1\u201312. doi:10.1016\/j.preteyeres.2013.05.002","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"ref35","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.ophtha.2014.02.009","article-title":"Systemic Medication and Intraocular Pressure in a British Population","volume":"121","author":"Khawaja AP","year":"2014","unstructured":"Khawaja AP, Chan MPY, Broadway DC, Garway-Heath DF, Luben R, Yip JLY, et al. Systemic Medication and Intraocular Pressure in a British Population. Ophthalmology. 2014;121(8):1501\u20137. doi:10.1016\/j.ophtha.2014.02.009","journal-title":"Ophthalmology"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9911540\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9911540\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:43:13Z","timestamp":1793130193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9911540\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":35,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9911540\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,6,11]]},"subtype":"preprint"}}